BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27534705)

  • 1. Drug approval and research assessment: arguments for reform.
    Abbasi K
    J R Soc Med; 2016 Sep; 109(9):323. PubMed ID: 27534705
    [No Abstract]   [Full Text] [Related]  

  • 2. European Medicines Agency: leave the UK but remain the same.
    Garattini L; Curto A
    J R Soc Med; 2016 Sep; 109(9):324-5. PubMed ID: 27609795
    [No Abstract]   [Full Text] [Related]  

  • 3. Keep science out of Europe's post-Brexit arguments.
    Nature; 2022 Feb; 602(7898):548. PubMed ID: 35197622
    [No Abstract]   [Full Text] [Related]  

  • 4. Health care reform: GOP's newest wedge issue.
    Keating T
    Nephrol News Issues; 2010 Dec; 24(13):13. PubMed ID: 21214064
    [No Abstract]   [Full Text] [Related]  

  • 5. Business of Health: International Healthcare.
    Berry MD
    Issue Brief Health Policy Track Serv; 2017 Dec; 2017():1-66. PubMed ID: 29359899
    [No Abstract]   [Full Text] [Related]  

  • 6. Can NHS politics, power and conflict ever be a good thing for nurses?
    Lees C
    Br J Nurs; 2016 Jul; 25(13):742-4. PubMed ID: 27409782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European health systems face scrutiny in US debate.
    Walgate R
    Lancet; 2009 Oct; 374(9699):1407-8. PubMed ID: 19866517
    [No Abstract]   [Full Text] [Related]  

  • 8. The Art of Repeal - Republicans' Health Care Reform Muddle.
    Oberlander J
    N Engl J Med; 2017 Apr; 376(16):1497-1499. PubMed ID: 28402249
    [No Abstract]   [Full Text] [Related]  

  • 9. Liberating the NHS; commissioning, outsourcing and a new politics debate.
    Regan P; Ball E
    Br J Community Nurs; 2010 Oct; 15(10):503-5. PubMed ID: 20966847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drug approval success rate in Europe in 2009.
    Eichler HG; Aronsson B; Abadie E; Salmonson T
    Nat Rev Drug Discov; 2010 May; 9(5):355-6. PubMed ID: 20431561
    [No Abstract]   [Full Text] [Related]  

  • 11. [Organization of the Federal Drug and Medical Products Institute in view of increased European competition].
    Kurth R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Mar; 51(3):340-4. PubMed ID: 18369569
    [No Abstract]   [Full Text] [Related]  

  • 12. You say Zantac, I say Xanax: a critique of drug trademark approval and proposals for reform.
    Gentin DA
    Food Drug Law J; 2000; 55(2):255-67. PubMed ID: 12269368
    [No Abstract]   [Full Text] [Related]  

  • 13. Rent increase hits Europe's drug regulator before Brexit move.
    Vesper I
    Nature; 2018 Apr; 556(7702):418. PubMed ID: 29691518
    [No Abstract]   [Full Text] [Related]  

  • 14. US government reopens as Republican effort to derail health act collapses.
    McCarthy M
    BMJ; 2013 Oct; 347():f6336. PubMed ID: 24141888
    [No Abstract]   [Full Text] [Related]  

  • 15. Academics across Europe join 'Brexit' debate.
    Cressey D
    Nature; 2016 Feb; 530(7588):15. PubMed ID: 26842034
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative effectiveness research.
    Stubenrauch JM
    Am J Nurs; 2009 Oct; 109(10):26-7. PubMed ID: 21753470
    [No Abstract]   [Full Text] [Related]  

  • 17. UK parliamentary report slams Medical Research Council.
    Barbour V;
    Lancet; 2003 Mar; 361(9363):1105. PubMed ID: 12672320
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug law reform, performativity and the politics of childhood.
    Flacks SJ
    Int J Drug Policy; 2018 Jan; 51():56-66. PubMed ID: 29202316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Republicans across US take aim at Planned Parenthood.
    Dyer O
    BMJ; 2015 Sep; 351():h4999. PubMed ID: 26384377
    [No Abstract]   [Full Text] [Related]  

  • 20. Health care debate 101.
    Keating T
    Nephrol News Issues; 2009 Sep; 23(10):21. PubMed ID: 19807001
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.